However, while impaired insulin action was considered a key part of the original fetal insulin hypothesis, studies of birthweight relating to monogenic lipodystrophies, paternal insulin resistance and the biology underlying shared birthweight and type 2 diabetes risk loci suggest this may be a less important factor in mediating the relationship between lower birthweight and type 2 diabetes risk. The gene discussed is INS; the disease is type 2 diabetes mellitus.